Phase II study of daunorubicin in previo
โ
Harvey, J. ;Bonnem, E. ;Grady, K. ;Goodman, A. ;Schein, P.
๐
Article
๐
1985
๐
John Wiley and Sons
๐
English
โ 111 KB
Fourteen patients with advanced measurable colorectal cancer were treated with daunorubicin hydrochloride (DNR). The drug was administered at a dose of 15 mg/m2 on day 1 through 3 and 8 through 10. After a Cday rest period DNR was given in weekly injections of 15 mg/m2. There were no partial or comp